Mubadala Bio has announced the rebranding of Al Ittihad Drug Store (IDS) and Global Medical Supply Chain (GMSC), marking a strategic milestone in the ongoing development of its integrated life sciences platform.
The announcement follows Mubadala Bio’s full acquisition of Al Ittihad Drug Store and Global Medical Supply Chain earlier this year.
The two companies operate under Mubadala Bio’s Pharma Logistics vertical, which integrates distribution, logistics, and supply chain capabilities to ensure the availability of essential medicines, medical devices, and innovative healthcare products across the UAE and the wider region.
The rebrand reflects Mubadala Bio’s vision of building a unified life sciences platform that is better positioned to advance innovation, strengthen healthcare resilience, and create long-term value.
As healthcare systems increasingly prioritize resilience, integration, and operational agility, IDS and GMSC are positioned to play a strategic role beyond traditional distribution and logistics, supporting end-to-end healthcare enablement across the value chain.
Image credits: Mubadala Bio | Cropped by GBN
Hamad Almarzooqi, Group Deputy CEO, Mubadala Bio, said that, “The rebrand of IDS and GMSC reflects Mubadala Bio’s long-term vision to build a more integrated and future-ready healthcare ecosystem. As both entities evolve to meet the changing needs of the healthcare sector, the new identity highlights their modernized approach in supporting seamless market access, logistics, distribution, and supply continuity.”
In recent months, both companies have expanded their capabilities and partnerships to capture broader opportunities across the life sciences sector. IDS signed an agreement with L-Nutra for the distribution of longevity products, and with Valeo Health to enable access to wellness products through online channels.
IDS has also recently signed agreements with leading multinational and regional companies, including Bayer and Globalpharma, to broaden access to a wider portfolio of healthcare products and critical therapies across the UAE.
